HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.

AbstractOBJECTIVES:
This study evaluated the efficacy of the pharmacokinetic/pharmacodynamic (PK/PD) index for increasing the success rate of linezolid treatment based on Monte Carlo simulation, and compared differences between the calculated PK/PD breakpoints and those defined by committee for critically ill patients with linezolid treatment.
METHODS:
A Monte Carlo simulation involving 10000 subjects was used to analyze the pharmacokinetic parameters and microbiological data of linezolid for an effectiveness evaluation at the corresponding AUC24/MIC values (area under the serum concentration-time curve over 24h/minimum inhibitory concentration).
RESULTS:
As the PK/PD index of linezolid increased from 80 to 120, the corresponding probability of target attainment (PTA) decreased from 99.91% to 18.97%, with a MIC of 2mg/l. Furthermore, the cumulative fraction of response (CFR) reached <90% for several pathogens at an AUC24/MIC of 100-120, revealing a relatively lower efficacy with recommended linezolid dosing.
CONCLUSIONS:
These findings reveal that the target AUC24/MIC value of 80-120 requires further classification for more accurate assessment of the linezolid dose regimen. At a MIC of ≥2mg/l, the clinical outcome varies greatly for different AUC24/MIC values when applying the same dose of linezolid. In such cases, we suggest optimized adjustment of the linezolid dosage regimen.
AuthorsHaiyan Dong, Jiao Xie, Lihong Chen, Taotao Wang, Jinyue Sun, Yingren Zhao, Yalin Dong
JournalInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Int J Infect Dis) Vol. 22 Pg. 35-40 (May 2014) ISSN: 1878-3511 [Electronic] Canada
PMID24603161 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Linezolid
Topics
  • Acetamides (blood, pharmacokinetics, pharmacology)
  • Anti-Bacterial Agents (blood, pharmacokinetics, pharmacology)
  • Area Under Curve
  • Computer Simulation
  • Critical Illness
  • Drug Dosage Calculations
  • Drug Resistance, Multiple, Bacterial
  • Enterococcus (drug effects, physiology)
  • Gram-Positive Bacterial Infections (blood, drug therapy, microbiology)
  • Humans
  • Linezolid
  • Methicillin-Resistant Staphylococcus aureus (drug effects, physiology)
  • Microbial Sensitivity Tests
  • Models, Statistical
  • Monte Carlo Method
  • Oxazolidinones (blood, pharmacokinetics, pharmacology)
  • Streptococcus pneumoniae (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: